JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB209236

重组Anti-LAG-3抗体[EPR20261]

Anti-LAG-3 antibody [EPR20261]

4

(1 Review)

|

(34 Publications)

Anti-LAG-3 antibody [EPR20261] (ab209236) is a rabbit monoclonal antibody detecting LAG-3 in Western Blot, Flow Cytometry, IP, IHC-P, ICC/IF. Suitable for Human.

- Biophysical QC for unrivalled batch-batch consistency
- Over 10 publications

查看别名

CD223, FDC, LAG3, Lymphocyte activation gene 3 protein, LAG-3

11 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • IHC-P

Lab

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)

Tissue Microarrays stained for "Anti-LAG-3 antibody [EPR20261]" using "ab209236"in immunohistochemical analysis. This table provides a detailed overview of positive (tick mark) and negative (cross mark) staining per sample type tested. The sections were pre-treated using Heat mediated antigen retrieval using ab93684 (Tris/EDTA buffer, pH 9.0). The sections were incubated with ab209236 at +4°C overnight followed by a ready to use Goat Anti-Rabbit IgG H&L (HRP polymer).

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • Flow Cyt

Supplier Data

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)

Flow cytometric analysis of HEK-293T (Human epithelial cell line from embryonic kidney) cells transfected with a GFP-tagged human LAG-3 construct labeling LAG-3 with ab209236 at 1/500 dilution (right) compared with a rabbit monoclonal IgG isotype control (ab172730; left). Goat anti rabbit IgG (Alexa Fluor® 647) ab150079 at 1/2000 dilution was used as the secondary antibody.

Note : Fresh cells without fixation and permeabilization were used to perform FC testing. Only GFP positive population results in LAG3 positive staining (Q2, right panel).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)

Immunohistochemical analysis of paraffin-embedded human tonsil tissue labeling LAG-3 with ab209236 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Sporadic cytoplasmic staining on immunocytes of human tonsil [PMID : 11527700; PMID : 16757686].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • Flow Cyt

Lab

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)

Flow cytometry staining of human peripheral blood mononuclear cells (PBMCs) (top) or PBMCs treated with 5 μg/ml phytohaemagglutinin (PHA) for 72 hours (bottom), with ab209236 (right) or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (left). PBMCs were incubated for 30 min on ice in 1x PBS containing 10 μg/ml human IgG and 10 % normal goat serum to block FC receptors and non-specific protein-protein interaction followed by the antibody ab209236 or Recombinant Rabbit IgG, monoclonal [EPR25A] - Isotype Control (1x 106 in 100 μl at 5.0 μg/ml (1/402)) for 30min on ice. The cells were simultaneously stained with CD3.

The secondary antibody Goat Anti-Rabbit IgG H&L (Alexa Fluor® 488) preadsorbed was incubated at 1/4000 for 30min on ice

Acquisition of >30000 events were collected using a 50 mW Blue laser (488nm) and 525/40 bandpass filter. Events were gated on viable cells.

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-LAG-3 antibody [EPR20261] (AB209236)

Immunohistochemical analysis of paraffin-embedded human tonsil Hodgkin's lymphoma labeling LAG-3 with ab209236 at 1/1000 dilution, followed by Goat Anti-Rabbit IgG H&L (HRP) Ready to use. Cytoplasmic staining on immunocytes of the human Hodgkin's lymphoma [PMID : 11527700; PMID : 16757686].

Counter stained with Hematoxylin.

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat Anti-Rabbit IgG H&L (HRP) Ready to use.

Perform heat mediated antigen retrieval with Tris/EDTA buffer pH 9.0 before commencing with IHC staining protocol.

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • Flow Cyt

Lab

Flow Cytometry - Anti-LAG-3 antibody [EPR20261] (AB209236)

Flow cytometric analysis of Human peripheral blood mononuclear cells treated with 1 μg/mL PHA for 3 days cells with ab209236 at 1/50 dilution (right) compared with a rabbit monoclonal IgG isotype control (ab172730; left). ab150077 at 1/2000 dilution was used as the secondary antibody.

Only the CD3+ population are also positive for LAG3. Gated on total viable cells.

Immunocytochemistry/ Immunofluorescence - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-LAG-3 antibody [EPR20261] (AB209236)

Immunofluorescent analysis of 4% paraformaldehyde-fixed, 0.1% Triton X-100 permeabilized HEK-293T (Human epithelial cell line from embryonic kidney) cells transfected with GFP-tagged LAG3 expression construct or GFP only, labeling LAG-3 with ab209236 at 1/100 dilution, followed by Goat anti-rabbit IgG (Alexa Fluor® 647) (ab150079) secondary antibody at 1/1000 dilution (green).

Confocal image showing positive staining on HEK-293T cells transfected with a GFP-tagged LAG3 expression construct.

The nuclear counter stain is DAPI (blue). Tubulin is detected with ab195889 (Anti-alpha Tubulin antibody [DM1A] - Microtubule Marker (Alexa Fluor® 594)) at 1/200 dilution (red).

Secondary antibody only control : Used PBS instead of primary antibody, secondary antibody is Goat anti-rabbit IgG (Alexa Fluor® 647) (ab150079) at 1/1000 dilution.

Immunoprecipitation - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • IP

Supplier Data

Immunoprecipitation - Anti-LAG-3 antibody [EPR20261] (AB209236)

LAG-3 was immunoprecipitated from 0.35 mg of HEK-293T (Human epithelial cell line from embryonic kidney) transfected with a GFP-tagged human LAG3 construct whole cell lysate with ab209236 at 1/30 dilution. Western blot was performed from the immunoprecipitate using ab209236 at 1/1000 dilution. VeriBlot for IP Detection Reagent (HRP) (ab131366), was used for detection at 1/10000 dilution.

Lane 1 : HEK-293T transfected with a GFP-tagged human LAG3 construct whole cell lysate 10 μg (Input).

Lane 2 : ab209236 IP in HEK-293T transfected with a GFP-tagged human LAG3 construct whole cell lysate.

Lane 3 : Rabbit monoclonal IgG (ab172730) instead of ab209236 in HEK-293T transfected with a GFP-tagged human LAG3 construct whole cell lysate.

Blocking and dilution buffer and concentration : 5% NFDM/TBST.

Exposure time : 1 second.

All lanes:

Immunoprecipitation - Anti-LAG-3 antibody [EPR20261] (ab209236)

Predicted band size: 57 kDa

false

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • WB

Unknown

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)

Primary loading control and concentration : Anti-GAPDH antibody [6C5] - Loading Control (ab8245) at 1/20000 dilution

Secondary loading control and concentration : Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) at 1/10000 dilution

Lanes 1-2 : Merged signal (red and green). Green – ab209236 observed at 54-70 kDa. Red - loading control ab8245 observed at 36 kDa.
ab209236 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800RCW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 10000 dilution for 1 hour at room temperature before imaging.

The expression profile observed in Jurkat is consistent with the literature (PMID : 25108024).

Negative control : Jurkat (PMID : 25108024)

Observed MW : 54-70 kDa

All lanes:

Western blot - Anti-LAG-3 antibody [EPR20261] (ab209236) at 1/500 dilution

Lane 1:

HDLM-2 (Human Hodgkin lymphoma ) whole cell lysate at 20 µg

Lane 2:

Jurkat (Human T cell leukemia T lymphocyte) whole cell lysate at 20 µg

Secondary

All lanes:

Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution

Predicted band size: 57 kDa

false

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • WB

Lab

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)

Blocking/Diluting buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-LAG-3 antibody [EPR20261] (ab209236) at 1/5000 dilution

Lane 1:

293T (Human embryonic kidney epithelial cell) transfected with an empty vector (vector control), containing a GFP tag, whole cell lysate at 15 µg

Lane 2:

293T transfected with LAG3 expression vector containing a GFP tag, whole cell lysate at 15 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 57 kDa

false

Exposure time: 5s

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)
  • WB

Supplier Data

Western blot - Anti-LAG-3 antibody [EPR20261] (AB209236)

Blocking/Dilution buffer : 5% NFDM/TBST.

All lanes:

Western blot - Anti-LAG-3 antibody [EPR20261] (ab209236) at 1/1000 dilution

All lanes:

Human LAG3 Fc chimera recombinant protein (aa23-450) at 0.01 µg

Secondary

All lanes:

Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution

Predicted band size: 57 kDa

Observed band size: 90 kDa

false

Exposure time: 1s

不同偶联物与剂型 (7)

关键信息

宿主种属

Rabbit

克隆

Monoclonal

克隆号

EPR20261

亚型

IgG

不含载体蛋白

No

反应种属

Human

应用

ICC/IF, IP, IHC-P, Flow Cyt, WB

applications

免疫原

The exact immunogen used to generate this antibody is proprietary information.

反应性数据

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "FlowCyt" : {"fullname" : "Flow Cytometry", "shortname":"Flow Cyt"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/30", "IP-species-notes": "<p></p>", "FlowCyt-species-checked": "testedAndGuaranteed", "FlowCyt-species-dilution-info": "1/500", "FlowCyt-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/100", "ICCIF-species-notes": "<p></p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/1000", "IHCP-species-notes": "<p>Different mRNA expression levels of LAG3 in brain have been reported in the literature (PMID: 1692078; PMID: 12825348). In IHC, under our experimental conditions, this antibody showed no positive staining on human cerebral cortex.</p>" } } }

产品详情

What is this antibody validated in?
Anti-LAG-3 antibody [EPR20261] (ab209236) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human samples.

What is the molecular weight of LAG-3?
Anti-LAG-3 [EPR20261] (ab209236) specifically detects a band for LAG-3 (UniProt: P18627) at a molecular weight of 54kDa.

Trusted by the scientific community
Anti-LAG-3 [EPR20261] (ab209236) was first used in a scientific publication in 2017 and has been cited over 10 times in peer-reviewed journals.

Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.

Other related products
We have a range of other formats of antibody clone [EPR20261] also available for your convenience: ab209236, PE - ab225484, Alexa Fluor® 488 - ab225485, Alexa Fluor® 647 - ab225486, Carrier free - ab227579, Alexa Fluor® 555 - ab280858, Carrier free - ab282638, Alexa Fluor® 594 - ab283627, ab307517, Carrier free - ab307518

Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

  • - High batch-to-batch consistency and reproducibility
  • - Improved sensitivity and specificity
  • - Long-term security of supply
  • - Animal-free batch production

For more information, read more on recombinant antibodies.

性能和储存信息

形式
Liquid
纯化工艺
Affinity purification Protein A
存储溶液
pH: 7.2 - 7.4 Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA
运输条件
Blue Ice
推荐的短期储存时间
1-2 weeks
推荐的短期储存条件
+4°C
推荐的长期储存条件
-20°C
分装信息
Upon delivery aliquot
储存信息
Avoid freeze / thaw cycle

补充信息

This supplementary information is collated from multiple sources and compiled automatically.

LAG-3 also known as CD223 is a transmembrane protein with a mass of approximately 70 kDa. It acts as a checkpoint molecule similar to CTLA-4 and PD-1 in the immune system. LAG-3 is expressed on activated T cells natural killer cells and some dendritic cells. It interacts with its ligand MHC class II leading to inhibition of cellular proliferation and cytokine secretion an important part of immune response regulation.
Biological function summary

LAG-3 is involved in maintaining immune homeostasis and preventing autoimmunity. It is not part of a complex but works in synergy with other immune checkpoint molecules. When interacting with MHC class II LAG-3 transmits inhibitory signals that attenuate immune cell responses. Its role in immune regulation helps to balance immune activation and tolerance which is essential for preventing tissue damage while protecting against pathogens.

Pathways

The inhibitory role of LAG-3 integrates into the T cell receptor (TCR) signaling pathway and is also linked to the PD-1 signaling pathway. In TCR signaling LAG-3 negatively regulates T cell activation. LAG-3 is functionally related to proteins like PD-1 and CTLA-4 sharing similar roles in immune checkpoint pathways that are critical for maintaining immune balance.

LAG-3 has links to cancer and autoimmune diseases. In cancer LAG-3 expression on tumor-infiltrating lymphocytes correlates with immune evasion by tumors. This relationship appears in various cancers including melanoma and renal cell carcinoma. In autoimmune diseases LAG-3's expression on regulatory T cells helps control conditions such as multiple sclerosis. It collaborates with CTLA-4 in modulating immune responses that prevent excessive immune activation and tissue damage associated with autoimmunity.

产品实验方案

For this product, it's our understanding that no specific protocols are required. You can visit:

靶点信息

Lymphocyte activation gene 3 protein : Inhibitory receptor on antigen activated T-cells (PubMed : 20421648, PubMed : 7805750, PubMed : 8647185). Delivers inhibitory signals upon binding to ligands, such as FGL1 (By similarity). FGL1 constitutes a major ligand of LAG3 and is responsible for LAG3 T-cell inhibitory function (By similarity). Following TCR engagement, LAG3 associates with CD3-TCR in the immunological synapse and directly inhibits T-cell activation (By similarity). May inhibit antigen-specific T-cell activation in synergy with PDCD1/PD-1, possibly by acting as a coreceptor for PDCD1/PD-1 (By similarity). Negatively regulates the proliferation, activation, effector function and homeostasis of both CD8(+) and CD4(+) T-cells (PubMed : 20421648, PubMed : 7805750, PubMed : 8647185). Also mediates immune tolerance : constitutively expressed on a subset of regulatory T-cells (Tregs) and contributes to their suppressive function (By similarity). Also acts as a negative regulator of plasmacytoid dendritic cell (pDCs) activation (By similarity). Binds MHC class II (MHC-II); the precise role of MHC-II-binding is however unclear (PubMed : 8647185).. Secreted lymphocyte activation gene 3 protein. May function as a ligand for MHC class II (MHC-II) on antigen-presenting cells (APC), promoting APC activation/maturation and driving Th1 immune response.
See full target information LAG3

文献 (34)

Recent publications for all applications. Explore the full list and refine your search

Frontiers in immunology 16:1656242 PubMed40895577

2025

PD-1 and LAG-3 were optimal combination of immune checkpoints for predicting poor clinical outcomes of patients with ovarian cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Yifan Wu,Cunte Chen,Yingwen Cui,Ruoyao Zou,Yaoxiang Yang,Fengjie Sun,Yanzi Du,Peipei Wang

Cells 14: PubMed40643462

2025

Insulin Modulates NK Cell Activity in Liver Fibrosis MASH Patients via the STING Pathway.

Applications

Unspecified application

Species

Unspecified reactive species

Johnny Amer,Ahmad Salhab,Amiram Ariel,Rifaat Safadi

Frontiers in immunology 16:1614683 PubMed40589739

2025

Machine learning-driven prediction of immune checkpoint inhibitor responses against cholangiocarcinoma: a bile biopsy perspective.

Applications

Unspecified application

Species

Unspecified reactive species

Dengyong Zhang,Xinrui Li,Zhonglin Wang,Jingyuan Fan,Yuhang Yang,Sophia Han,Wanliang Sun,Dongdong Wang,Shuo Zhou,Zhong Liu,Shihao Chen,Yan Yang,Yan Zhu,Zheng Lu

International journal of molecular sciences 26: PubMed40565313

2025

Immune-Checkpoint Expression in Breast Cancer Patients: Clinicopathological Implications: A Retrospective Case Series Study.

Applications

Unspecified application

Species

Unspecified reactive species

Angel Quiroz-Bolaños,Antonio Quintero-Ramos,Juliana Marisol Godínez-Rubí,Ramon Franco-Topete,Porfirio Gutiérrez González,Bricia M Gutiérrez-Zepeda,Denisse S Becerra-Loaiza,Antonio Topete,Cesar de Loera-Rodriguez,Alicia Del Toro-Arreola,Adrián Daneri-Navarro

Discover oncology 16:1170 PubMed40542277

2025

Genomic and immunological profiling reveals novel prognostic biomarkers for limited-stage small cell lung cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Ye Li,Xiaolong Ma,Zhiyi Wan,Pengfei Bao,Enli Zhang,Lihua Liu,Shunchang Jiao,Shengjie Sun

CytoJournal 22:41 PubMed40469710

2025

Matrix gla protein mediates CD8 T-cell exhaustion to facilitate immune evasion in intrahepatic cholangiocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Xiaohan Cao,Shiqian Lang,Yuchi Xie,Kai Zheng,Jun Liu

Thoracic cancer 16:e70016 PubMed40001320

2025

A Comprehensive Analysis of FGF/FGFR Signaling Alteration in NSCLC: Implications in Prognosis and Microenvironment.

Applications

Unspecified application

Species

Unspecified reactive species

Ziling Huang,Leyao Li,Xu Cai,Shen Wang,Yun Jia,Yuan Li

PLoS biology 23:e3002974 PubMed39964974

2025

The cholesterol 24-hydroxylase CYP46A1 promotes α-synuclein pathology in Parkinson's disease.

Applications

Unspecified application

Species

Unspecified reactive species

Lijun Dai,Jiannan Wang,Lanxia Meng,Xingyu Zhang,Tingting Xiao,Min Deng,Guiqin Chen,Jing Xiong,Wei Ke,Zhengyuan Hong,Lihong Bu,Zhentao Zhang

Translational lung cancer research 13:3538-3554 PubMed39830736

2025

Characteristics of the immune microenvironment and their clinical significance in lung adenocarcinoma patients with different ALK fusion variants.

Applications

Unspecified application

Species

Unspecified reactive species

Yinbo Xiao,Hao Wang,Junliang Lu,Junyi Pang,Shiyi Liu,Yang Zhou,Xiaohua Shi,Zhiyong Liang

Cancer immunology, immunotherapy : CII 74:57 PubMed39751903

2025

Prognostic immune markers in esophageal cancer patients managed with trimodal therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Mark K Farrugia,Elizabeth A Repasky,Minhui Chen,Kristopher Attwood,Kayla Catalfamo,Hanna Rosenheck,Song Yao,David M Mattson,Sarbajit Mukherjee,Moshim Kukar,Agnieszka K Witkiewicz,Anurag K Singh
View all publications

Abcam Product Promise

我们致力于为您的研究提供高质量的试剂,为您科研的每一步提供支持。若我们的产品未能达到预期性能,我们向您提供 Abcam Product Promise 保障。
详情请参阅我们的条款与条件。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com